Statistics for Application of an active comparator-based benefit-risk Assessment in evaluating clinical trial design features of a new chemical entity using a Bayesian decision-theoretic framework.
Total visits
views | |
---|---|
Application of an active comparator-based benefit-risk Assessment in evaluating clinical trial design features of a new chemical entity using a Bayesian decision-theoretic framework. | 49 |
Total visits per month
views | |
---|---|
January 2024 | 1 |
February 2024 | 0 |
March 2024 | 4 |
April 2024 | 3 |
May 2024 | 1 |
June 2024 | 0 |
July 2024 | 0 |
File Visits
views | |
---|---|
Goel_umn_0130E_11194.pdf | 44 |
Top country views
views | |
---|---|
United States | 17 |
China | 7 |
Ireland | 4 |
Germany | 2 |
Finland | 2 |
United Kingdom | 2 |
India | 2 |
Singapore | 2 |
Taiwan | 2 |
Argentina | 1 |
Hong Kong SAR China | 1 |
Indonesia | 1 |
Mongolia | 1 |
Netherlands | 1 |
Romania | 1 |
Russia | 1 |
South Africa | 1 |
Zambia | 1 |
Top city views
views | |
---|---|
Ashburn | 6 |
Dublin | 3 |
Chicago | 2 |
Annandale | 1 |
Beijing | 1 |
Boardman | 1 |
Cape Town | 1 |
Cary | 1 |
Central | 1 |
Cheltenham | 1 |
Des Moines | 1 |
Dongguan | 1 |
Hinckley | 1 |
Jakarta | 1 |
Minneapolis | 1 |
Mountain View | 1 |
Saint Paul | 1 |
Shenzhen | 1 |
Singapore | 1 |
Taichung | 1 |
Taipei | 1 |
Vladivostok | 1 |
Zhengzhou | 1 |